← Back to headlines
Wave Life Sciences Stock Plunges After Disappointing Obesity Drug Data
Wave Life Sciences experienced a significant drop in its stock market value today, March 26, following the release of disappointing data from its high-dose obesity drug trials.
26 Mar, 21:50 — 26 Mar, 21:50
Sources
Showing 1 of 1 sources
